Experiment 1324398
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Cannabis sativa (CANNABACEAE) |
| Citation | JOHNSON,JR: BURNELL-NUGENT,M: LOSSIGNOL,D: GANAE-MOTAN,ED: POTTS,R: FALLON,MT:. (2010). MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY, SAFETY, AND TOLERABILITY OF THC:CBD EXTRACT AND THC EXTRACT IN PATIENTS WITH INTRACTABLE CANCER-RELATED PAIN. 39(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | THIS TWO-WEEK (TWO-DAY BASELINE AND TWO WEEK TREATMENT), MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY EVALUATED THE EFFICACY OF THC:CBD EXTRACT AND THC EXTRACT ALONE, IN THE ANALGESIC MANAGEMENT OF PATIENTS WITH CANCER PAIN. CANNABIS SATIVA L. CONTAINS 60 OR MORE CANNABINOID COMPOUNDS, INCLUDING DELTA-9-TETRAHYDROCANNABINOL (THC) AND CANNABIDIOL(CBD). THIS STUDY, SATIVEX (CONTAINING A MIXTURE OF THC AND CBD) WAS EVALUATED FOR ITS ANALGESIC EFFECT. THE PRIMARY ANALYSIS OF CHANGE FROM BASELINE IN MEAN PAIN NUMERICAL RATING SCALE (NRS) SCORE WAS STATISTICALLY SIGNIFICANTLY IN FAVOR OF THC:CBD COMPARED WITH PLACEBO. |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE VARIABLE |
| Extract | TYPE EXT NOT STATED |